The 12 closest competitors and alternatives to ViAqua Therapeutics among biotechnology companies — ranked by similarity to what ViAqua Therapeutics actually does, not by market-cap band.
Subscribe to see ViAqua Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ViAqua Therapeutics is a Haifa-based biotechnology company focused on aquaculture health management. The firm develops affordable, specific, and effective oral health treatments to combat viral and bacterial diseases in shrimp and other aquatic species.
ViAqua Therapeutics is a biotechnology company headquartered in Israel, founded in 2014. It has raised at least $12.6M across the 2 funding rounds on record. Its most recent funding round raised $8.3M in September 2023. Xcout tracks 6 named people at ViAqua Therapeutics, including Shai Ufaz (CEO & Co-Founder | Molecular biology).
At least $12.6M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $8.3M | 7 named | |
| — | $4.3M | 7 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to ViAqua Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Okapi Sciences was a Belgian biotechnology company focused on discovering and developing antiviral medicines, particularly for veterinary applications and companion animals. It served the animal-health pharmaceutical market by developing treatments for viral diseases.
Biotech
ViroVet is a biopharmaceutical company headquartered in Leuven, Belgium, established in 2015. The company focuses on addressing the significant threat of viral diseases.
Biotech
Loyal is a biotechnology company developing longevity medications designed to extend the healthspan and lifespan of dogs by targeting the underlying biological processes of aging. The company provides veterinary professionals with clinical resources, education, and trial opportunities while offering dog owners information on senior canine care and aging.
Life Sciences
ASTRA Therapeutics is a biotechnology and drug design company focused on animal health and anti-parasitic drug discovery. Located at the Swiss Innovation Park Innovaare in Villigen, Switzerland, the company leverages atomic resolution to craft next-generation small-molecule treatments against parasitic diseases.
Biotech
ZIVO Bioscience, Inc. is a research and development firm that specializes in the creation and commercialization of natural bioactive compounds. These unique ingredients, derived from its proprietary algae cultures, are licensed and sold to manufacturers producing goods for animal health, human consumption, dietary supplements, and medical foods. The company operates at the intersection of biotechnology and agricultural technology, boasting a comprehensive intellectual property portfolio. This includes distinct algal and bacterial strains, advanced biologically active molecules and complexes, innovative production and cultivation techniques, and various inventions, some patented and others pending approval, all geared towards improving human and animal well-being. Its product applications are broad, addressing areas such as promoting gut health in poultry, combating bovine mastitis, improving joint function in canines, modulating the human immune system, providing algal biomass for direct human consumption, and offering biomass-based solutions for skin care and anti-aging. Founded originally as Health Enhancement Products, Inc., the company officially rebranded to ZIVO Bioscience, Inc. in October 2014. Its corporate operations are based in Bloomfield Hills, Michigan.
Similar biotechnology company
ELIAS Animal Health is a medical biotechnology company focused on advancing a pipeline of immunotherapies, including a unique treatment protocol and adoptive cell therapy that vaccinates companion animals using their own cancer cells.
Similar biotechnology company
Curelab Veterinary Inc. is a biotechnology company headquartered in Boston, Massachusetts, devoted to developing innovative veterinary therapeutics and treatments to help pets combat cancer and live longer lives.
Health Care
Intervacc is a biotechnology company that develops modern animal health vaccines based on recombinant protein technology. The company serves the animal healthcare market with products like Strangvac, aimed at improving animal welfare and reducing the global reliance on antibiotics.
Pharmaceuticals
JA Saúde Animal is a Brazilian pharmaceutical and veterinary company that researches, develops, and manufactures animal health products. It serves the livestock sector by providing medications, supplements, and therapeutic solutions for cattle, pigs, horses, goats, and sheep.
Veterinary Pharmaceuticals
Drag Pharma is a pharmaceutical company that researches, develops, produces, and commercializes veterinary medicines and products for pets and livestock.
Pharmaceuticals
Vetnostrum is a company focused on animal health products, including veterinary medicines, functional feed additives, and nutritional supplements for both livestock and companion animals. As one of Taiwan's leading large-scale veterinary pharmaceutical manufacturers, it leverages human-grade pharmaceutical standards across its R&D and production. The company holds numerous domestic and international product licenses and serves clients like feed mills, livestock farms, and veterinary hospitals, while also developing its own pet brand, Koolpal.
Pharmaceuticals
Jaguar Health, Inc., a commercial-stage pharmaceutical firm, specializes in developing prescription therapies for both human and animal patients afflicted by gastrointestinal ailments, particularly chronic and severe diarrhea. Its operations are structured into two distinct divisions: Human Health and Animal Health. Presently, the company markets Mytesi, an approved medication providing symptomatic relief for noninfectious diarrhea experienced by adults with HIV/AIDS undergoing antiretroviral therapy. Beyond its commercial product, Jaguar Health is actively advancing Crofelemer, the active pharmaceutical ingredient in Mytesi, for a broad spectrum of additional indications. These include managing diarrhea associated with cancer therapy, seeking orphan drug designation for symptomatic relief in infants and children with congenital diarrheal disorders, and for adult and pediatric patients suffering from short bowel syndrome with intestinal failure. Further potential applications encompass supportive care for diarrhea linked to inflammatory bowel diseases, diarrhea-predominant irritable bowel syndrome (IBS-D), and idiopathic or functional diarrhea. Their pipeline also features lechlemer, a next-generation anti-secretory agent being developed to combat cholera. In the animal health sector, they are developing Canalevia, an oral, plant-derived drug candidate designed to address chemotherapy-induced diarrhea and exercise-induced diarrhea in canines. Established in 2013, Jaguar Health, Inc. maintains its headquarters in San Francisco, California.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for ViAqua Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →